Health Ministry unveils AIDS and TB treatment App

0


The Ministry of Health and Childcare has launched the Zimbabwe clinical resources app as part of innovations to infuse e-health in workforce development.

Ministry of Health capacity development and public-private partnerships programmes coordinator (AIDS and TB unit) Albert Mulingwa said the ministry had over the years printed volumes of guidelines that would be points of reference for health workers in their line of work.
The process was cumbersome as the volumes of printed guidelines had to be distributed, first, into major towns and cities before they reach their final destinations, sometimes in the remotest of areas in the country.

He was presenting at the recently held Zimbabwe Medical Association (ZiMA) symposium in digital health.

“e-health has helped us as a ministry deal with our specific problems and save up money that we used to direct towards printing large volumes of books that sometimes even get to the end of their use before they even reach the facilities.”

With the Zimbabwe Clinical Resources Mobile App, health care workers will find all the Ministry’s AIDS and TB program guidelines and the operational service delivery manual. The application also has an interactive consultation tool that allows the health worker to define the profile of their patient and provide details on the recommended treatment regimen and dosing for HIV and TB.

The application also helps health care workers stay up to date on changes within the Ministry of Health by accessing the memorandums and news updates in real-time. This means they will be able to implement their work better and provide better health services to the public.


A key feature of the Zimbabwe Clinical Resources Mobile App is that it can be used offline. There is no need for data or wifi once the content is downloaded the first time. The ZCRA application is readily available on the Google play store.

Educate Unveils Diaspora School Fees Solution

Previous article

EWI offloads Econet Media Stake

Next article

Comments

Leave a Reply